Renalys Pharma reports major phase III success for Sparsentan in Japanese IgA nephropathy patients
The study, which enrolled 35 Japanese patients, evaluated the percent change from baseline in the 24-hour urine protein-to-creatinine ratio
The study, which enrolled 35 Japanese patients, evaluated the percent change from baseline in the 24-hour urine protein-to-creatinine ratio
Relmada expects to initiate its Phase 3 program in the first half of 2026
Encouraging early detection and breaking the silence around men’s health
Experts urge early detection & better access to care
Akums Drugs & Pharmaceuticals has launched Dapagliflozin + Pioglitazone tablets, a dual-action therapy for diabetes management
Pflow is a revolutionary, disposable, and portable home based urine flow measurement test
The report also revealed that 87% of physicians agreed that FEE recommendations would help to improve the speed of recovery
Organization to provide vaccinations & treatments for several monsoon related diseases and illnesses across all 102 clinics
Subscribe To Our Newsletter & Stay Updated